After a successful 2022 edition that brought together professionals from more than 184 countries, Arab Health exhibition has established itself as the federating event of the health ecosystem in the Near and Middle East zone. The four days of the exhibition will be punctuated by various demonstrations and business meetings.
This year, Business France brings together 88 French healthcare experts on 3 pavilions which will be located in:
- Za’abeel 2 Hall for the “medical equipment & devices” sector
- Sheikh Rachid Hall for the “orthopaedics & physiotherapy / rehabilitation” sector
- Sheikh Saeed 1 Hall for the “imaging & diagnostics” sector
As a unique occasion for French companies to provide their expertise on essential health topics, create and develop meaningful connections while also supporting the innovation in the healthcare sector in the UAE and the region, the latest technologies showcased will be on disposables, orthopaedics, healthcare and general services, imaging, medical devices, IT, wellness and prevention, infrastructure, assets, and more. The event will also be marked by the visit of Mr. Jean Patrick Lajonchère, Export Health Federator, to the Minister for Europe and Foreign Affaires and to the Minister Foreign Trade and Attractiveness on January 30 and 31.
A STRONG FRENCH PRESENCE IN THE UAE & STRATEGIC KEY PARTNESHIPS
In a country extremely committed in terms of improving the healthcare system, France has a strong presence with renowned and qualified actors such as Ipsen, Servier, Sanofi, Pierre Fabre ..to name just a few. Arab Health will be the opportunity for more French actors to come and explore the market and develop strong ties with the local partners.
In September 2022, four major not-for-profit French hospitals: Curie Institute, Paris Saint-Joseph and Marie- Lannelongue Hospitals, Rothschild Foundation Hospital and the medical services and consulting company C3Medical have announced their collaboration in opening an office in Dubai in order to better address the needs of the population in middle east & strengthen to relations with local ecosystem.
UAE’s healthcare investments are moving well beyond investing in pharmaceutical production are going into the very core of generating the knowhow – and potential cure – of diseases and their treatments.
In mid-June 2022, French pharmaceutical giant Sanofi signed an agreement with the Abu Dhabi Ministry of Health aiming to work on four distinct healthcare priorities, involving extensive R&D as well.
As part of this, Sanofi will extend its hand for a clinical research project and patient recruitment protocol as well as participate in DoH’s Cancer Advisory Group to ‘develop policies significant to the elderly cancer-patient community’. Both will also ‘co-create’ a high-risk population screening project that will support in the detection of rare metabolic diseases utilising AI tools.
FRANCE RECOGNIZED WORLDWIDE FOR ITS MEDICAL EXCELLENCE
France enjoys a worldwide renowned image for the quality of its healthcare offer as well as for its industrial, technical and scientific expertise. It stands out all over the world thanks to its health performance. A leader in the fight against cancer, it has one of the best cure rates and has more than 130 research projects and 13 Nobel Prizes in medicine.
On the occasion of the French participation to the 47th edition of Arab Health, Axel Baroux, French Trade & Invest Commissioner & Managing Director of Business France Middle East, commented: “France is delighted to renew its commitment to taking part at the Arab Health Show. I believe that French Healthcare companies, these already present in the UAE and the French exhibiting companies at Arab Health wailing for new partnerships can build jointly with the local healthcare professionals a strong new healthcare system.”
“Facilitating access to care, improving health system and providing new technologies and services for the patients are a common ambition between the French-UAE healthcare authorities and systems” added Baroux.
INNOVATION AT THE HEART OF FRENCH COMPANIES’ STRATEGIES
French companies are redoubling their ingenuity by proposing innovative concepts. R&D efforts are considerable: 6% of sales in 2020, making innovation the central element in the development strategies of French companies. France’s expertise is based on national research centers, competitive clusters and universities that place it at the forefront of global health research. France is ranked number 5th in the world for the number of patents filed.
The French Company Rebalance Tech has developed a revolutionary mental wellness & neuro-relaxation solution: Rebalance Impulse®. This stimulation and cognitive training device based on applied neuroscience is mainly devoted to fighting chronic stress, improving sleep quality, and increasing vitality. The effectiveness of Rebalance Impulse® has been the subject of clinical studies, published in the world-renowned scientific journal: Frontiers in Psychology.
Rebalance Impulse® operates in the following markets: medwellness, professional sports, healthcare, and corporate. The programs integrated in this innovative and non-invasive solution target: Neuro-Relaxation, Sleep, Addictions, Memory & Concentration, Pain Management, Emotions Management, Slimming, Brain Anti-Aging, Long Covid Recovery, and Post-Traumatic Stress Disorder (EMDR).
MEDTECH: A DYNAMIC SECTOR IN FULL EXPANSION
French industrial production includes 1,440 MedTech companies, 93% of which are small and medium-sized companies that together employ 88,000 people. The industry generated a turnover of €30.7 billion in 2021, of which €10 billion came from exports (+4% compared to 2020). Some companies generate more than 50% of their turnover abroad, such as Médipréma, which has developed a phototherapy solution adapted for neonatology.
The MedTech sector is very dynamic thanks to its innovative companies. It includes all medical devices – surgical robots, telemedicine objects, medical imaging, but also artificial hearts as well as respirators, The European market is the second largest in the world, valued at 140 billion euros per year.
The potential of French medical technologies is growing rapidly thanks to artificial intelligence, connected objects and quantum technology. These are all applications that should continue to develop strongly, while adapting to the different needs of patients, but also of health professionals. With the company ATA Medical, which has adapted to the recent health issues: thanks to the DOPAIR1000, a specialized and connected solution for air treatment in hygiene environments.